Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$8,241,461
+$6,645,085 QoQ
Shares Held
32,751
+346.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,021
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Howard Capital Management Inc. holds $46,726,837 across 9 Drug Manufacturers - General names. ABBV ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,165 | $8,593,916 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
32,751 | $8,241,461 | |
| 3 | AMGN |
Amgen Inc
|
21,489 | $7,781,596 | |
| 4 | JNJ |
Johnson & Johnson
|
19,725 | $5,009,558 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
39,385 | $4,975,900 | |
| 6 | PFE |
Pfizer Inc
|
193,027 | $4,648,090 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,206 | $2,662,389 | |
| 8 | OGN |
Organon & Co.
|
178,927 | $2,422,671 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,241,461 | 32,751 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,596,376 | 7,340 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $7,541,997 | 33,008 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,214,554 | 31,159 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5,209,610 | 28,066 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $4,380,225 | 20,906 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,788,208 | 21,318 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $3,750,935 | 18,994 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $773,898 | 4,512 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $345,807 | 1,899 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||